Given the small size of our study population, the higher frequency of DSP-MG in women may not be significant, while the lower positive response rates may be due to technical issues and the limited number of samples.
← all excerpts
AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?
1
—
—